Azul S.A.
Azul S.A. (AZUL) Financial Performance & Income Statement Overview
Analyze Azul S.A. (AZUL) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Azul S.A. (AZUL) Income Statement & Financial Overview
Review Azul S.A. AZUL income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.39B | $5.55B | $5.13B | $4.17B |
| Cost of Revenue | $3.86B | $3.97B | $3.54B | $3.41B |
| Gross Profit | $1.53B | $1.58B | $1.66B | $759.61M |
| Gross Profit Ratio | $0.28 | $0.28 | $0.32 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $245.80M | $478.28M | $409.60M | $344.91M |
| Operating Expenses | $961.80M | $458.71M | $562.76M | $318.004M |
| Total Costs & Expenses | $4.82B | $4.42B | $4.10B | $3.73B |
| Interest Income | $31.60M | $25.00M | $40.58M | $34.56M |
| Interest Expense | $2.39B | $1.31B | $1.22B | $1.17B |
| Depreciation & Amortization | $815.20M | $711.95M | $626.12M | $611.42M |
| EBITDA | $3.99B | -$2.40B | $2.24B | -$2.06B |
| EBITDA Ratio | $0.74 | -$0.43 | $0.44 | -$0.49 |
| Operating Income | $570.60M | $1.12B | $1.03B | $441.18M |
| Operating Income Ratio | $0.11 | $0.20 | $0.20 | $0.11 |
| Other Income/Expenses (Net) | $212.50M | -$5.53B | -$666.20M | -$4.28B |
| Income Before Tax | $1.65B | -$4.41B | $361.00M | -$3.84B |
| Income Before Tax Ratio | $0.31 | -$0.80 | $0.07 | -$0.92 |
| Income Tax Expense | $15000.00 | -$250000.00 | $700000.00 | -$32.46M |
| Net Income | $783.10M | -$4.41B | $360.30M | -$3.81B |
| Net Income Ratio | $0.15 | -$0.80 | $0.07 | -$0.91 |
| EPS | $3.86 | -$12.69 | $1.04 | -$10.96 |
| Diluted EPS | $1.83 | -$12.69 | $1.04 | -$10.96 |
| Weighted Avg Shares Outstanding | $427.90M | $347.87M | $347.70M | $347.51M |
| Weighted Avg Shares Outstanding (Diluted) | $427.90M | $347.87M | $347.70M | $347.51M |
The company's financials show resilient growth, with revenue advancing from $4.17B in Q2 2024 to $5.39B in Q1 2025. Gross profit remained healthy with margins at 28% in Q1 2025 compared to 18% in Q2 2024. Operating income hit $570.60M last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.99B. Net income rose to $783.10M, while earnings per share reached $3.86. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan